Zacks: Brokerages Expect Perrigo Company PLC (PRGO) to Post $0.95 EPS
Equities research analysts expect Perrigo Company PLC (NYSE:PRGO) to announce earnings of $0.95 per share for the current quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Perrigo’s earnings, with the highest EPS estimate coming in at $1.07 and the lowest estimate coming in at $0.60. Perrigo reported earnings of $1.26 per share during the same quarter last year, which indicates a negative year over year growth rate of 24.6%. The company is scheduled to announce its next earnings report on Tuesday, May 14th.
On average, analysts expect that Perrigo will report full year earnings of $4.17 per share for the current year, with EPS estimates ranging from $3.93 to $4.40. For the next year, analysts anticipate that the business will post earnings of $4.54 per share, with EPS estimates ranging from $4.18 to $5.04. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that follow Perrigo.
Perrigo (NYSE:PRGO) last issued its earnings results on Wednesday, February 27th. The company reported $0.97 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.98 by ($0.01). The firm had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.18 billion. Perrigo had a return on equity of 10.74% and a net margin of 2.77%. Perrigo’s quarterly revenue was down 6.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.28 earnings per share.
Hedge funds have recently bought and sold shares of the company. Atlas Capital Advisors LLC acquired a new position in shares of Perrigo in the fourth quarter valued at approximately $26,000. Moody National Bank Trust Division acquired a new position in shares of Perrigo in the first quarter valued at approximately $32,000. Oregon Public Employees Retirement Fund increased its stake in shares of Perrigo by 3,574.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,430,805 shares of the company’s stock valued at $37,000 after buying an additional 1,391,870 shares during the period. Advisor Group Inc. increased its stake in shares of Perrigo by 822.2% in the fourth quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock valued at $41,000 after buying an additional 962 shares during the period. Finally, Covington Capital Management acquired a new position in shares of Perrigo in the fourth quarter valued at approximately $46,000. 85.29% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE:PRGO traded down $1.04 on Thursday, hitting $48.82. The company had a trading volume of 1,278,452 shares, compared to its average volume of 1,373,728. Perrigo has a 1-year low of $36.28 and a 1-year high of $82.95. The company has a market cap of $6.77 billion, a P/E ratio of 10.73, a P/E/G ratio of 2.58 and a beta of 1.31. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.32.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Friday, March 1st were issued a $0.19 dividend. The ex-dividend date of this dividend was Thursday, February 28th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.56%. Perrigo’s dividend payout ratio (DPR) is currently 16.70%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Further Reading: The risks of owning bonds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.